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Abstract: Human and animals differ widely in their responses to virus infections. Viruses may induce barely discernible 
symptoms in some of them and severe, life-threatening illness in others.  
Evidence is accumulating that genetic background is one of the major factors involved, thus, identifying genes that 
control the response to virus infection is a crucial step in elucidating how they might affect the pathophysiological 
processes underlying the severity of the disease induced.   
In this review, it’s illustrated how mouse-virus systems are being used to identify candidate virus-resistance genes, and 




Resumo: Os Homens e os animais diferem grandemente nas suas respostas às infecções virais. Os vírus podem induzir, 
em alguns, sintomas ligeiros, enquanto que em outros podem provocar patologias graves mesmo mortais.  
Acumulam-se evidências que o património genético é um dos factores primordiais a condicionar e contribuir para a 
complexidade das interações vírus-hospedeiro. A identificação de genes com papel na resposta à infecção viral tornou-
se pois o tema de investigação de muitos laboratórios, com o objectivo de elucidar os processos fisiopatológicos que 
regem e determinam esse tipo de resposta. 
Neste artigo de revisão pretende-se ilustrar como o modelo murino têm sido utilizado para a identificação de genes de 
resistência viral, e como estes podem funcionar como base para a descoberta de genes homólogos em outras espécies. 
na elucidação dos mecanismos de resistência, e em novos componentes da reunir todos os genes de resistência viral 






Human and animals differ widely in their 
responses to virus infections. Viruses may 
induce barely discernible symptoms in some of 
them and severe, life-threatening illness in 
others (1, 2, 3, 4, 21). These differences reflect both 
the complex, intimate, and multifaceted nature 
of virus-host interactions and the variables that 
can influence these interactions. Viruses elicit a 
complex temporal sequence of stringently 
regulated innate and adaptive immune 
responses. These responses are essential for 
recovery, but they also contribute to disease 
symptoms. Optimal innate and adaptive 
immune responses are therefore balanced at a 
narrow interface between ineffectual and overly 
aggressive. Variables of age, gender, immune 
status, and genetic background influence the 
availability and form of the host metabolites on 
which viruses depend as well as the magnitude 
and effectiveness of the ensuing host response 
(11)
. Evidence is accumulating that genetic 
background is one of the major factors 
involved, thus, identifying genes that control 
the response to virus infection is a crucial step 
in elucidating how they might affect the 
pathophysiological processes underlying the 
severity of the disease induced (1, 2, 3, 4).   
 
The mouse model 
The large size and complexity of the human and 
domestic animals genome, have limited the 
identification and functional characterization of 
components of the innate immune system that 
play a critical role in front-line defence against 
invading virus. However, the advent of new 
technologies and resources, including the 
complete sequence of mammalian genomes, has 
had a dramatic impact on the genetic analysis of 
susceptibility to infections. Besides that, the 
study of the genomic organization and content 
of widely divergent vertebrate species has 
shown a remarkable degree of evolutionary 
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conservation, which enables the cross-species 
comparison and analysis of newly discovered 
genes.  
Application of comparative genomics to host 
resistance will rapidly expand our 
understanding of human and domestic animals 
immune defence by facilitating the translation 
of knowledge acquired through the study of 
model organisms (9, 28, 38, 47).  
The mice have been for quite a long the model 
of choice (20, 21, 34), more is known now about 
genetic control of resistance to viruses in mice 
than any other animal. They own this success to 
the low costs incurred, the existence of 
thousands of inbred strains, and the fact that the 
mouse is the species with the greatest density of 
known genetic markers, which facilitates the 
tracing of the alleles partly or wholly 





The mouse genome contains two related 
interferon-regulated genes, Mx1 and Mx2.  
The Mx1 was both the first virus-resistance 
gene to be cloned and the first to be used to 
identify a human homologue, it encodes a type I 
interferon inducible nuclear protein that affords 
specific protection against influenza viruses. 
Only three mouse strains, A2G, SL/NiA and 
T9, express the antiviral form of protein; other 
mouse strains have deletions in the Mx1 gene 
that result in truncated proteins that are devoid 
of antiviral activity (45).  
The Mx2 gene is non-functional in all 
laboratory mice strains examined, since its open 
reading frame (ORF) is interrupted by an 
insertional mutation and a subsequent 
frameshift mutation. However, the Mx2 mRNA 
of cells from feral mouse strains NJL(Mus 
musculus musculus) and SPR (Mus spretus) 
that differs from that of the laboratory mouse 
strains tested  is expressed upon interferon 
treatment and inhibits vesicular stomatitis virus, 
and hantavirus replication (30, 31). 
 
The Hv2 
Hv2, another mouse virus-resistance gene, 
controls resistance to mouse hepatitis virus 
(MHV), a large-enveloped RNA virus that is 
distantly related to human enteric and 
respiratory coronaviruses. As natural pathogens 
of mice, MHV strains may cause either 
localized intestinal infections or generalized 
infections that emanate from the respiratory 
tract. All MHV strains appear to use members 
of the biliary glycoprotein subfamily as receptor 
proteins (19). The principal receptors for MHV 
are several isoforms encoded by the biliary 
glycoprotein 1 (Bgp1) gene on the proximal end 
of mouse chromosome 7 (39).  
     The SJL inbred mouse strain, unlike almost 
all other inbred strains, is highly refractory to 
MHV infection. The Bgp1b (Hv2r) allele of 
SJL mice contains divergent sequences in the 
N-terminal virus-binding domain (33), 
particularly in the critical residues 38-43 (39). 
The altered Bgp1b isoform remains a functional 
virus receptor, but its affinity for MHV is 
reduced by one to two orders of magnitude (37).  
 
The Flv 
Innate resistance to flavivirus, which includes 
human pathogens such as yellow fever, Dengue, 
and West Nile virus was demonstrated in mice 
in the 1920s as a monogenic autosomal 
dominant inheritance. The alleles that 
determined resistance and susceptibility were 
designated Flvr and Flvs, respectively (27). 
Resistant mice are susceptible to infections with 
other types of viruses but are resistant to all 
flaviviruses (44). Resistant mice can be infected 
by flaviviruses, but the virus titers in their 
tissues are lower by 1,000-10,000 times than 
those in the tissues of susceptible animals, and 
the spread of the infection in resistant mice is 
slower (17, 26).  Most commonly used inbred 
laboratory mouse strains have a homozygous 
flavivirus-susceptible genotype. Only the Det, 
BSVR, BRVR, CASA/Rk, CAST/Ei, 
MOLD/Rk, and PRI inbred strains have the 
resistant allele (7).  
 
The Cmv1 
Murine cytomegalovirus (MCMV) is a natural 
pathogen of mice that has been widely used as a 
model of human cytomegalovirus infection. 
Differences in susceptibility were observed 
among inbred mouse strains, being the 
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C57BL/6 resistant and BALB/c susceptible to 
MCMV infection (41). MCMV titers in the 
spleens of susceptible mice were inversely 
correlated with their ability to mount an 
effective Natural Killer (NK) cell response (41, 
42)
 suggesting an important role of those cells in 
the innate control of cytomegalovirus infection. 
Later on, this has been demonstrated in humans 
with a rare disorder characterized by complete 
absence of NK cells and in genetically deficient 
mice lacking NK cells or being depleted of 
those cells by treatment with anti-NK cell 
antibodies (7). A single dominant locus, named 
Cmv1, located in the natural killer gene 
complex on mouse chromosome 6 controls the 
NK efficient response and consequently the 
resistance to MCMV infection in mice (18, 24, 41, 
42, 43)
. The alleles of the Cmv1 locus can confer 
either susceptibility (Cmv1s, a recessive allele) 




Ectromelia virus, is a naturally occurring 
pathogen of mice and belongs to the Poxviridae 
family. Orthopoxviruses cause localized or 
generalized infections in a variety of species. 
Systemic infections which include smallpox 
(variola) in human beings are among the most 
lethal infections known (22, 23). 
Most inbred strains of mice are highly 
susceptible to the lethal effects of ectromelia 
virus infection, but C57BL and AKR strains are 
highly resistant (9, 13). Susceptible strains 
succumb to the acute necrotizing effects of 
ectromelia virus on liver, spleen, and bone 
marrow, whereas resistant strains develop mild, 
transient inflammatory changes in target organs 
(12)
. 
Resistance to mousepox is inherited as a 
polygenic trait (14, 48). At least four autosomal 
dominant genes, named Rmp-1, Rmp-2, Rmp-3, 
and Rmp-4, control resistance to mousepox in 
C57BL mice. The genes that control resistance 
to mousepox are of interest because they are 
dominant over ectromelia virus genes that 
encode virokines and other virulence factors 
and because they may be some of the best 
examples of mouse genes that have responded 
to selection pressure by a highly lethal naturally 
occurring virus. 
 
The Fv-1, Fv-4 
In 1957, Charlotte Friend described a novel 
retroviral disease in mice characterized by 
splenic enlargement, erythroleukemia, and 
death (25). This rapidly progressive disease, now 
known as Friend disease, has provided a 
powerful tool for the study of multistage 
carcinogens and, most recently, has provided 
major insights into the molecular mechanisms 
of leukemia resistance. 
A number of host genes have been identified 
that affect the susceptibility of mice to Friend 
virus–induced erythroleukemia. These genes 
can be divided into several groups based on 
their proposed mechanism of resistance: group 
1: interference with retroviral infection (Fv1, 
Fv4); group 2:  altered  immune response (Fv3, 
Rfv1, Rfv2, Rfv3); and group 3:  regulators of 
erythroid cell proliferation and differentiation 
(Fv2, Fv5, Kit, and Mgf) (5).  
In terms of virus-resistance genes only the first 
group, that consists of genes that dominantly 
interfere with the infection of target cells by the 
virus, will be mencioned. We have then, the 
Fv1 gene that encodes a Gag-related protein, 
which interferes with the retroviral life cycle (6) 
and the Fv4 gene that encodes a protein which 
blocks ecotropic viral receptors (29). 
Differences in susceptibility among mouse 
strains allowed the identification of those genes. 
In the Fv1 gene, two alleles were discovered by 
this way: Fv1n and Fv1b. These alleles are able 
to block specific subclasses of MLV (8). Fv1n, 
found in NIH Swiss mice, is able to block 
replication of B-tropic MLV while allowing 
replication of N-tropic virus, and Fv1b, found in 
BALB/c mice, acts vice versa. In the Fv4 gene, 
the dominant allele was first described in a G 
stain of laboratory mouse, and subsequently, in 
several wild mouse populations in Japan, 
Southeast Asia and western North America (36, 
46)
 as  a single dominant gene for the resistance 
against MLV infection, independent of Fv1.  
 
H-2 class I genes 
Theiler's virus causes a persistent and 
demyelinating infection of the central nervous 
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system of the mouse, which is one of the best 
animal models to study multiple sclerosis. 
All inbred mouse strains inoculated 
intracranially with Theiler’s virus present with 
early encephalomyelitis. However, not all of 
them remain persistently infected. The 
C57BL/6 strain clear the infection after 
approximately 2 weeks. On the contrary, the 
susceptible strains (SJL and FVB/N) remain 
infected for life (15, 16, 40). 
The susceptibility of the mouse to persistent 
infection is multigenic. H2 class I genes have a 
major effect (32), While most of the non-H2 
susceptibility genes group control viral load 
during persistence by modulating the immune 
response. Among several non-H2 susceptibility 
loci, Tmevp3 appears to regulate the expression 
of important cytokines (10).  
      
CONCLUSION 
     These examples illustrate how mouse-virus 
systems are being used to identify candidate 
virus-resistance genes. They provide the probes 
to detect functional homologues of resistance 
genes that are shared by rodent and other 
species. They delineate novel genetic 
mechanisms of resistance and highlight specific 
genetically complex and polymorphic 
components of the innate immune system as 
sources of variation in responses to viruses. 
Other benefits are likely to emerge as more 
mouse virus-resistance genes are identified and 
characterized. Clearly, not all details of virus-
restriction pathways are conserved between 
mice and other species, but even where 
differences exist, functional similarities may be 
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